CIBC Bancorp USA’s Microbot Medical MBOT Stock Holding History

CIBC Bancorp USA’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,870,000	Closed	-$4.51M	–	1997
2026 Q1	$4.51M	Buy	+1,870,000	New	+$4.18M	0.01%	738

Other funds holding MBOT

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

CIBC Bancorp USA's MBOT Position: Q2 2026 in Review

CIBC Bancorp USA sold out of Microbot Medical (MBOT) in Q2 2026, closing a stake of 1,870,000 shares — an estimated $4.51M sold.

CIBC Bancorp USA first reported a position in MBOT in Q1 2026 and held it in 1 quarter. The position peaked at $4.51M in Q1 2026. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

CIBC Bancorp USA reported no remaining Microbot Medical position as of Q2 2026 after selling out during the quarter.
CIBC Bancorp USA sold 1,870,000 Microbot Medical shares in Q2 2026, an estimated $4.51M.
CIBC Bancorp USA first reported a position in Microbot Medical in Q1 2026 and held it in 1 quarter.
CIBC Bancorp USA's Microbot Medical position peaked at $4.51M in Q1 2026.
71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.